aminoimidazole carboxamide has been researched along with msh, 4-nle-7-phe-alpha- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, B; Li, JY; Mulholland, MW; Wu, X; Zhang, C; Zhang, W | 1 |
1 other study(ies) available for aminoimidazole carboxamide and msh, 4-nle-7-phe-alpha-
| Article | Year |
|---|---|
Melanocortin-4 receptor activation promotes insulin-stimulated mTOR signaling.
Topics: Affinity Labels; alpha-MSH; Aminoimidazole Carboxamide; Animals; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Hypoglycemic Agents; Insulin; Mitogen-Activated Protein Kinases; Receptor, Melanocortin, Type 4; Ribonucleotides; Signal Transduction; TOR Serine-Threonine Kinases | 2010 |